ClinicalTrials.gg
RecruitingNCT07228611Updated Nov 2, 2026

Assessment and Comparison of Osteoporosis Risk Factors After Stroke

An observational study in Stroke and Osteoporosis, sponsored by Ankara Etlik City Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 55 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Ankara Etlik City Hospital · Observational

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.
Updated Nov 2, 2026Primary completion movedStudy completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
84
Ages
55 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 487 studies in Stroke with a site in Turkey — 96 open to participants now, 109 under way, 3 of them phase 3. Stroke · Turkey.

Planned enrollment
49th of 164
84 · median 63
Started
2025
with 70 others
Observational
164 of 487
36 open now
Primary completion
2026-12
later than 69 of 108 live
Registered
372nd of 487
by date

Among the 487 studies in Stroke with a site in Turkey, this one is the 49th largest by planned enrollment of the 164 observational ones that give a count, is one of 71 that started in 2025, is one of 164 observational ones, reaches primary completion later than 69 of the 108 other live ones, and was the 372nd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

96 of the 487 studies in Stroke with a site in Turkey are open now. Recruiting first, the newest first:

91 more — sign in →

All 96 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 55 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 487 studies in Stroke with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effects of stroke and associated clinical, functional, nutritional, and muscular factors, including handgrip strength, on bone mineral density and osteoporosis by comparing patients with subacute stroke, patients with chronic stroke, and non-stroke controls. By identifying factors associated with reduced bone mineral density and osteoporosis across these groups, the study is expected to contribute to the identification of high-risk patients and provide a basis for future research aimed at improving screening and treatment strategies. No significant risks are anticipated from participation in this study.

Read the detailed description

The primary outcomes of this study will be bone mineral density (BMD), expressed in g/cm², and T-scores measured by dual-energy X-ray absorptiometry (DXA) at the lumbar spine and hip. Additionally, the prevalence of osteoporosis and low bone mass will be evaluated using appropriate diagnostic criteria.

Secondary outcomes will include handgrip strength measured using a hand dynamometer, anterior thigh and anterior arm muscle thickness assessed by ultrasonography (mm), motor recovery evaluated using the Brunnstrom Recovery Stages, spasticity assessed using the Modified Ashworth Scale (MAS), functional independence measured by the Modified Barthel Index (MBI), and fall-related self-efficacy evaluated using the Modified Falls Efficacy Scale (MFES). Biochemical parameters, including serum vitamin D (ng/mL), albumin (g/dL), and prealbumin (mg/dL), will also be recorded. These outcomes will be used to investigate potential factors associated with reduced BMD and osteoporosis.

03

Conditions studied

  • Stroke
  • Osteoporosis
04

Who can participate

The criteria were revised on the registry on Nov 2, 2026. See what changed

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Fifty-six stroke patients receiving inpatient treatment will be evaluated. In addition, patients who have visited the outpatient clinic and have already undergone BMD scanning for osteoporosis screening, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be randomly included in the study.

Eligibility criteria

Inclusion Criteria:

  1. Diagnosis of ischemic or hemorrhagic stroke
  2. Between 1 week and 6 months or >1 year has passed since the date of the event
  3. Being between 55 and 85 years of age

Exclusion Criteria:

  1. The patient has additional neurological conditions besides stroke
  2. The patient has a psychiatric condition
  3. History of recurrent stroke
  4. BMD scan performed within the last year for stroke patients
  5. Having received osteoporosis treatment before or after the stroke
  6. The patient having a fragility fracture before the stroke
  7. The patient having a hip fracture or hip prosthesis
  8. The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture)
  9. The patient has an additional disease or medication use that could cause secondary osteoporosis
  10. The patient's stroke did not cause physical function loss Inclusion Criteria for Non-Stroke Controls

No history of ischemic or hemorrhagic stroke.

Being between 55 and 85 years of age.

Ability to undergo the required clinical assessments and DXA measurements.

Exclusion Criteria for Non-Stroke Controls

Presence of a neurological condition causing significant physical functional impairment.

Presence of a psychiatric condition that may interfere with participation in the study or completion of assessments.

History of any cerebrovascular event, including .

Having undergone a BMD scan within the last year.

Having received osteoporosis treatment.

History of fragility fracture.

History of hip fracture or presence of a hip prosthesis.

Presence of any medical or musculoskeletal condition causing significant physical functional impairment or mobility limitations (e.g., amputation or severe fracture).

Presence of any disease or medication use associated with secondary osteoporosis.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

TIA (transient ischaemic attack)

A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.

Stroke symptoms need emergency care at once, even if they go away.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
84 participants (estimated)
Patient registry
No

Groups and cohorts

  • Subacute Stroke

    Patients for whom 1 week to 6 months have passed since the incident

    Diagnostic Test: Bone Mineral Density

  • Chronic Stroke

    Patients for whom more than one year has passed since the date of the incident

    Diagnostic Test: Bone Mineral Density

  • Non stroke control

    Diagnostic Test: Bone Mineral Density

Interventions

  • Diagnostic testBone Mineral Density

    Patients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.

06

What researchers measure

Primary outcomes

  1. Bone Mineral Density

    Bone mineral density (BMD) will be assessed in patients with stroke using dual-energy X-ray absorptiometry (DXA). Measurements will be performed at the lumbar spine and hip. BMD values will be recorded in grams per square centimeter (g/cm²), and the corresponding T-scores will also be documented for each anatomical site.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

Secondary outcomes

  1. Brunnstrom

    Brunnstrom Recovery Stages will be used to assess motor recovery in patients with stroke. This assessment classifies motor recovery into six stages, ranging from flaccidity (Stage I) to near-normal voluntary movement and coordination (Stage VI). The upper extremity, hand, and lower extremity will be evaluated separately, with higher stages indicating better motor recovery.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  2. Modified Barthel Index

    The Modified Barthel Index (MBI) will be used to assess functional independence in activities of daily living in patients with stroke. The index evaluates 10 activities, including feeding, bathing, dressing, toileting, transfers, and mobility. Total scores range from 0 to 100, with higher scores indicating greater functional independence.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  3. Modified Ashworth Scale

    The Modified Ashworth Scale (MAS) will be used to assess muscle spasticity in patients with stroke. The scale evaluates resistance to passive movement using six grades (0, 1, 1+, 2, 3, and 4), with higher grades indicating greater muscle tone and resistance to passive movement.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  4. Modified Falls Efficacy Scale (MFES)

    The Modified Falls Efficacy Scale (MFES) will be used to assess fall-related self-efficacy in patients with stroke. The scale consists of 14 items evaluating confidence in performing daily activities without falling. Each item is scored from 0 to 10, with higher scores indicating greater confidence and lower fear of falling.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  5. Vitamin D

    Vitamin D status will be assessed by measuring serum 25-hydroxyvitamin D \[25(OH)D\] levels. Results will be recorded in ng/mL and used to evaluate vitamin D status in patients with stroke.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  6. Handgrip strength (kg)

    Patients' muscle strength will be measured using a Baseline Digital Hand Dynamometer at 198 LB/90 kg for both the dominant and non-dominant extremities.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  7. Anterior thigh and anterior arm muscle thickness (mm)

    Regional sarcopenia of the plegic and non-plegic extremities will also be assessed using the STAR formula with measurements of anterior thigh muscle thickness and anterior arm muscle thickness by ultrasound.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  8. Prealbumine

    Prealbumin levels will be assessed by measuring serum prealbumin concentrations. Results will be recorded in mg/dL and used as a biochemical indicator of nutritional status in patients with stroke.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

  9. Albumine

    Serum albumin levels will be measured and recorded in g/dL as a biochemical parameter reflecting nutritional and inflammatory status in patients with stroke.

    Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Dec 2025 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 2, 2026: primary completion May 2026 → Dec 2026 and completion May 2026 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2025
First posted
Nov 14, 2025
StartActual
Dec 5, 2025
Primary completionEst.
Dec 1, 2026was May 2026
CompletionEst.
Dec 1, 2026was May 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
May 1, 2026→Dec 1, 2026
Nov 2, 2026
Study completion
May 1, 2026→Dec 1, 2026
Nov 2, 2026
Eligibility
2 criteria edited, 15 added
What changed in the criteria
  • AddedInclusion Criteria:
  • EditedFollowed byDiagnosis of ischemic or hemorrhagic stroke
  • AddedExclusion Criteria:
  • EditedThe patient's stroke did not cause physical function loss Inclusion Criteria for Non-Stroke Controls
  • AddedNo history of ischemic or hemorrhagic stroke.
  • AddedBeing between 55 and 85 years of age.
  • AddedAbility to undergo the required clinical assessments and DXA measurements.
  • AddedExclusion Criteria for Non-Stroke Controls
  • AddedPresence of a neurological condition causing significant physical functional impairment.
  • AddedPresence of a psychiatric condition that may interfere with participation in the study or completion of assessments.
  • AddedHistory of any cerebrovascular event, including transient ischemic attack.
  • AddedHaving undergone a BMD scan within the last year.
  • AddedHaving received osteoporosis treatment.
  • AddedHistory of fragility fracture.
  • AddedHistory of hip fracture or presence of a hip prosthesis.
  • AddedPresence of any medical or musculoskeletal condition causing significant physical functional impairment or mobility limitations (e.g., amputation or severe fracture).
  • AddedPresence of any disease or medication use associated with secondary osteoporosis.
Nov 2, 2026
Interventions
Arm changed Healthy Volunteer→Non stroke control
Nov 2, 2026
Primary outcomes
1 time frame changed, 1 description edited
What changed in the outcomes
  • Time frameBone Mineral DensityFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • DescriptionBone Mineral Density: how it is measured was reworded
Nov 2, 2026
Secondary outcomes
2 edited, 3 time frame changed, 4 added, 2 removed, 3 description edited
What changed in the outcomes
  • ChangedBefore Baseline Digital Hand Dynamometer 198 LB/90 kgNow Handgrip strength (kg)Time frame: First day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • ChangedBefore Measurements of quadriceps muscle thickness and biceps muscle thicknessNow Anterior thigh and anterior arm muscle thickness (mm)Time frame: First day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • AddedModified Falls Efficacy Scale (MFES)Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • AddedVitamin DTime frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • AddedPrealbumineTime frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • AddedAlbumineTime frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • RemovedModified Fall Impact ScaleTime frame: First day of hospitalization
  • RemovedVitamin D, prealbumin, and albuminTime frame: First day of hospitalization
  • Time frameBrunnstromFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • Time frameModified Barthel IndexFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • Time frameModified Ashworth ScaleFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
  • DescriptionBrunnstrom: how it is measured was reworded
  • DescriptionModified Ashworth Scale: how it is measured was reworded
  • DescriptionModified Barthel Index: how it is measured was reworded
Nov 2, 2026
Contact
Study contact changed: •••0000→•••0000; added a•••@hotmail.com · •••0000. See the current contact
Nov 2, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Ankara Etlik City Hospital · Ankara, Turkey (Türkiye)Contact •••0000→•••0000
Nov 2, 2026
Title
AssesmentAssessment and Comparison of Osteoporosis Risk Factors After Stroke
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Primary completion May 1, 2026→Dec 1, 2026
    Study completion May 1, 2026→Dec 1, 2026
    Eligibility 2 criteria edited, 15 added
    What changed in the criteria
    • AddedInclusion Criteria:
    • EditedFollowed byDiagnosis of ischemic or hemorrhagic stroke
    • AddedExclusion Criteria:
    • EditedThe patient's stroke did not cause physical function loss Inclusion Criteria for Non-Stroke Controls
    • AddedNo history of ischemic or hemorrhagic stroke.
    • AddedBeing between 55 and 85 years of age.
    • AddedAbility to undergo the required clinical assessments and DXA measurements.
    • AddedExclusion Criteria for Non-Stroke Controls
    • AddedPresence of a neurological condition causing significant physical functional impairment.
    • AddedPresence of a psychiatric condition that may interfere with participation in the study or completion of assessments.
    • AddedHistory of any cerebrovascular event, including transient ischemic attack.
    • AddedHaving undergone a BMD scan within the last year.
    • AddedHaving received osteoporosis treatment.
    • AddedHistory of fragility fracture.
    • AddedHistory of hip fracture or presence of a hip prosthesis.
    • AddedPresence of any medical or musculoskeletal condition causing significant physical functional impairment or mobility limitations (e.g., amputation or severe fracture).
    • AddedPresence of any disease or medication use associated with secondary osteoporosis.
    Primary outcomes 1 time frame changed, 1 description edited
    What changed in the outcomes
    • Time frameBone Mineral DensityFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • DescriptionBone Mineral Density: how it is measured was reworded
    Secondary outcomes 2 edited, 3 time frame changed, 4 added, 2 removed, 3 description edited
    What changed in the outcomes
    • ChangedBefore Baseline Digital Hand Dynamometer 198 LB/90 kgNow Handgrip strength (kg)Time frame: First day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • ChangedBefore Measurements of quadriceps muscle thickness and biceps muscle thicknessNow Anterior thigh and anterior arm muscle thickness (mm)Time frame: First day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • AddedModified Falls Efficacy Scale (MFES)Time frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • AddedVitamin DTime frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • AddedPrealbumineTime frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • AddedAlbumineTime frame: First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • RemovedModified Fall Impact ScaleTime frame: First day of hospitalization
    • RemovedVitamin D, prealbumin, and albuminTime frame: First day of hospitalization
    • Time frameBrunnstromFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • Time frameModified Barthel IndexFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • Time frameModified Ashworth ScaleFirst day of hospitalization → First day of hospitalization for stroke patient, during an outpatient visit for non stroke control
    • DescriptionBrunnstrom: how it is measured was reworded
    • DescriptionModified Ashworth Scale: how it is measured was reworded
    • DescriptionModified Barthel Index: how it is measured was reworded
    Interventions Arm changed Healthy Volunteer→Non stroke control
    Contact Study contact changed: •••0000→•••0000; added a•••@hotmail.com · •••0000. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Ankara Etlik City Hospital · Ankara, Turkey (Türkiye)Contact •••0000→•••0000
    Title AssesmentAssessment and Comparison of Osteoporosis Risk Factors After Stroke
    + 5 other changes: index terms, verification date, description, conditions and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07228611
Responsible party
Ayse Naz Kalem (PM&R Specialist, Ankara Etlik City Hospital) — Principal investigator
First posted
Nov 14, 2025
Start date
Dec 5, 2025
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Nov 2, 2026

Study contacts

Ayşe Naz Kalem Özgen, specialist
Contact
kalemnaz@gmail.com
+90 312 797 00 00
Aliye Aygün, Specialist
Contact
aliyeaygunn@hotmail.com
+90 312 797 00 00
Ayşe Naz Kalem, Specialist
principal investigator · Ankara Etlik City Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion